Status:

UNKNOWN

Optimised Pacing Program

Lead Sponsor:

University of Leeds

Collaborating Sponsors:

National Institute for Health Research, United Kingdom

Conditions:

Pacemaker Complication

Congestive Heart Failure

Eligibility:

All Genders

16+ years

Phase:

PHASE3

Brief Summary

Permanent pacemakers are a common treatment for slow heart beats. In the UK 300,000 people have a pacemaker, and each year another 36,000 receive them. All of these patients are usually seen yearly to...

Detailed Description

Permanent pacemaker implantation is a safe, life-prolonging and cost-effective treatment for bradycardia. An estimated 300,000 people in the UK have a pacemaker and there are 36,000 new implants per y...

Eligibility Criteria

Inclusion

  • Pacemaker implantation

Exclusion

  • Dementia, unwilling to fill in quality of life questionnaires, unwilling to sign consent form

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2019

Estimated Enrollment :

1793 Patients enrolled

Trial Details

Trial ID

NCT01819662

Start Date

August 1 2013

End Date

February 28 2019

Last Update

December 19 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Bradford Hospitals NHS Foundation Trust

Bradford, Yorkshire, United Kingdom

2

Harrogate Hospital Foundation Trust

Harrogate, Yorkshire, United Kingdom

3

Leeds General Infirmary

Leeds, United Kingdom